BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34373101)

  • 1. Molecular Pathology of Mature Lymphoid Malignancies.
    Ware AD; Davis K; Xian RR
    Surg Pathol Clin; 2021 Sep; 14(3):529-547. PubMed ID: 34373101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Mature Lymphoid Malignancies.
    Ware AD; Davis K; Xian RR
    Clin Lab Med; 2024 Jun; 44(2):355-376. PubMed ID: 38821649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
    Slack GW
    Surg Pathol Clin; 2023 Jun; 16(2):433-442. PubMed ID: 37149368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma cytogenetics.
    Dave BJ; Nelson M; Sanger WG
    Clin Lab Med; 2011 Dec; 31(4):725-61, x-xi. PubMed ID: 22118746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
    Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
    Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of molecular biology in the diagnosis of lymphoid neoplasms.
    Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Lymphoid Neoplasms.
    Ho C; Kluk MJ
    Surg Pathol Clin; 2016 Sep; 9(3):489-521. PubMed ID: 27523974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow biopsies of patients with hematopoietic and lymphoid disorders - epidemiology, chromosomal aberrations and molecular pathology.
    Hehne S; Schäfer SM; Richter P; Geier C; Chen Y; von Deimling A; Petersen I
    Pathol Res Pract; 2012 Sep; 208(9):510-7. PubMed ID: 22795690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetics of lymphomas.
    Campbell LJ
    Pathology; 2005 Dec; 37(6):493-507. PubMed ID: 16373229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis and classification of lymphoproliferative disorders on fine-needle aspiration.
    Zhang S; Abreo F; Lowery-Nordberg M; Veillon DM; Cotelingam JD
    Cancer Cytopathol; 2010 Apr; 118(2):105-12. PubMed ID: 20340097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to lymphoma diagnosis.
    Harris NL; Stein H; Coupland SE; Hummel M; Favera RD; Pasqualucci L; Chan WC
    Hematology Am Soc Hematol Educ Program; 2001; ():194-220. PubMed ID: 11722985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.
    Migliazza A; Lombardi L; Rocchi M; Trecca D; Chang CC; Antonacci R; Fracchiolla NS; Ciana P; Maiolo AT; Neri A
    Blood; 1994 Dec; 84(11):3850-60. PubMed ID: 7949142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization and cytogenetics of hemopoietic malignancies: new developments.
    Cherif D; Berger R
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):45-7. PubMed ID: 8511041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
    Rossi D; Ciardullo C; Gaidano G
    Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cardiac lymphoma: molecular cytogenetic characterization of a rare entity.
    Schell AJ; Xu Y; Baetz T; Harrison K; Ropchan G; LeBrun D; Feilotter H
    Cardiovasc Pathol; 2009; 18(2):92-9. PubMed ID: 18402841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.
    Ma ES
    Methods Mol Biol; 2017; 1541():279-293. PubMed ID: 27910030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.
    Nowotny H; Karlic H; Grüner H; Hirsch J; Vesely M; Nader A; Heinz R
    Ann Hematol; 1996 May; 72(5):291-301. PubMed ID: 8645741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent chromosomal abnormalities in lymphomas in fine needle aspirates of lymph node.
    Trcić RL; Sustercić D; Kuspilić M; Jelić-Puskarić B; Fabijanić I; Kardum-Skelin I
    Coll Antropol; 2010 Jun; 34(2):387-93. PubMed ID: 20698107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.
    Bogusz AM; Bagg A
    Leuk Lymphoma; 2016 Sep; 57(9):1991-2013. PubMed ID: 27121112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.